IN2014CH01195A - - Google Patents

Download PDF

Info

Publication number
IN2014CH01195A
IN2014CH01195A IN1195CH2014A IN2014CH01195A IN 2014CH01195 A IN2014CH01195 A IN 2014CH01195A IN 1195CH2014 A IN1195CH2014 A IN 1195CH2014A IN 2014CH01195 A IN2014CH01195 A IN 2014CH01195A
Authority
IN
India
Prior art keywords
relates
present
sorafenib
compositions
pharaiaceutical
Prior art date
Application number
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Podili Khadgapathi
Ghosh Soumik
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to IN1195CH2014 priority Critical patent/IN2014CH01195A/en
Publication of IN2014CH01195A publication Critical patent/IN2014CH01195A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IN1195CH2014 2014-03-10 2014-03-10 IN2014CH01195A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1195CH2014 IN2014CH01195A (es) 2014-03-10 2014-03-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1195CH2014 IN2014CH01195A (es) 2014-03-10 2014-03-10

Publications (1)

Publication Number Publication Date
IN2014CH01195A true IN2014CH01195A (es) 2015-09-18

Family

ID=54395537

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1195CH2014 IN2014CH01195A (es) 2014-03-10 2014-03-10

Country Status (1)

Country Link
IN (1) IN2014CH01195A (es)

Similar Documents

Publication Publication Date Title
PH12019500627A1 (en) Affinity-oligonucleotide conjugates and uses thereof
MX2023008693A (es) Polinucleotidos moduladores.
IL276695B (en) Antibodies, pharmaceutical preparations and their uses
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
SG10201803042PA (en) Anti-tim-3 antibodies
MY191581A (en) Anti-pd-1 antibodies
GEP20217239B (en) Pharmaceutical composition
GB2541571A (en) Pharmaceutical compositions
HK1256414A1 (zh) 新穎醣類抗體、醫藥組成物及其用途
PL3223796T3 (pl) Kompozycje farmaceutyczne, ich wytwarzanie i zastosowania
IN2014MU00303A (es)
HK1256674A1 (zh) 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
IL248785B (en) Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
IL290114A (en) Pharmaceutical preparations, their preparation and uses
MX2017000862A (es) Formulacion de factor viii.
MX2018005785A (es) Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
IN2014CH00840A (es)
PL3229843T3 (pl) Kompozycja farmaceutyczna, wytwarzanie i zastosowanie tej kompozycji
PH12017500071A1 (en) Therapeutic agent for keratoconjunctive disorder
IN2014CH01195A (es)
IN2014CH00035A (es)
UA106905U (uk) Фармацевтична композиція